Clinical trial Recruiting at 1 site Phase1; Phase2 Interventional Ages 10 Months to 14 Months

Using a bioengineered tissue to treat cleft palate in children

Official title: Phase I-IIa, Randomized, Controlled, Open-label, Single-center Clinical Trial to Evaluate Safety, Feasibility, and Efficacy of the Use of BIOCLEFT in the Treatment of Patients With Cleft Palate

Run by Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental · NCT06408337 · Data updated 2026-11-12

This study is testing a new bioengineered tissue to see if it can help children with cleft palate heal better than the usual surgery.

Quick facts

PhasePhase1; Phase2
Study typeInterventional
Ages10 Months to 14 Months
SexAll
Enrollment15 (estimated)
SponsorFundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental
Academic / other
Locations1 site (Granada, Spain/Granada)
StatusRecruiting
StartedApril 17, 2024
Main results expectedApril 17, 2028
Study endsDecember 17, 2028
Registry record updatedMay 10, 2024
Trial IDNCT06408337 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are pediatric patients diagnosed with total unilateral non-syndromic cleft lip and palate who are scheduled for surgical correction.

Probably not a fit

Patients with active infections, severe systemic disorders, or other congenital malformations may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the safety, feasibility, and efficacy of BIOCLEFT, a bioengineered palatal mucosa substitute, in pediatric patients with total unilateral non-syndromic cleft lip and palate. The trial consists of two phases: an initial non-randomized phase involving 5 patients followed by a randomized phase with an additional 10 patients. Participants will receive either the investigational treatment or standard surgical reconstruction, with follow-up assessments conducted over 24 months to monitor outcomes. The study aims to determine if this innovative approach can improve tissue repair and patient recovery compared to standard care.

Why it matters

Potential benefit: If successful, this treatment could enhance healing and reduce complications for children undergoing surgery for cleft palate.

How similar studies have gone: While this approach is innovative, similar studies using tissue engineering for cleft palate repair have shown promising results, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pediatric patients, of both sexes.
* Diagnosis of total unilateral non-syndromic cleft lip and palate (FLPNS) that will undergo surgery for correction.
* Children who have previously donated a sample of oral mucosa during the cleft lip repair procedure (cheiloplasty).
* Informed consent signed by one or both parents (or legal guardian) adequately informed of the study and willing to follow the trial procedures and instructions.

Exclusion Criteria:

* Active infectious diseases.
* Allergies or hypersensitivity to any of the components/excipients of the Investigational Product.
* Severe hematological disorders/blood dyscrasias.
* Severe hepatic or renal dysfunction/failure.
* Serious endocrine disorders/dysfunctions.
* Malignant neoplasms
* Active HIV, HBV or HCV infection.
* Metabolic bone diseases (Paget's disease, hypercalcemia, etc.).
* Children with cleft lip and palate who present other congenital malformations that, in the opinion of the researcher, could affect the result of the study or the interpretation of the results of the study.
* Any other pathology that in the opinion of the investigator should not be included in the study for other medical or social reasons.

Where it's running

  • University Hospital Virgen de las Nieves
    Granada, Spain/Granada, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.